The Ognjen "Ogi" Kovacevic
T-Cell Lymphoblastic Lymphoma/ALL Patient Advocacy Program

Literature, news and videos pertinent to
The Ognjen "Ogi" Kovacevic T-Cell Lymphoblastic Lymphoma/ALL Patient Advocacy Program

Cancer gene therapy advances

FDA Approves Belinostat for Peripheral T-Cell Lymphoma 1

FDA Approves Belinostat for Peripheral T-Cell Lymphoma 2

Tiny capsule effectively kills cancer cells

Seattle Genetics Reports Data from Phase I Trial of ADCETRIS® (Brentuximab Vedotin) in Front-line Ma

Life-Saving DNA Test Overlooked in Rise of Colon Cancer

SPRYCEL(R) (dasatinib) Receives FDA Priority Review For The Treatment Of Adult Patients With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase

'Missing Silencer' Can Trigger Leukaemia

Celator® Pharmaceuticals Presents Data On Combining CPX-351 With Clofarabine Or Azacytidine At The European Hematology Association Congress

Micromet's Blinatumomab Induces Durable Remissions In Patients With Relapsed Non-Hodgkin's Lymphoma

Protein That Predicts Prognosis Of Leukemia Patients May Also Be A Therapeutic Target

Identification Of Factors Behind Blood-Making Stem Cells May Impact Leukemia Treatment

Quantum Dot Technique For Cancer Biopsy Diagnosis

Allos Therapeutics, Inc. (ALTH) Cancer Drug Gets FDA Nod

For more information about this special program, please click on.....

To support this program, please click below.

Donate

We are always looking for updated RSS newsfeeds for the The Ognjen "Ogi" Kovacevic T-Cell Lymphoblastic Lymphoma/ALL Patient Advocacy Program at ICAN. If you have suggestions, please email us at OgiKovacevic Program@askican.org.

Please encourage family and friends to join our Cancer Research Literature teams for this Program by emailing ICAN at OgiKovacevic Program@askican.org.  We would like additional Research Team Leaders at ICAN for this named program to be medical students, physicians, nurses, or post-doctoral students in the sciences.  

Web Research Interns for the The Ognjen "Ogi" Kovacevic T-Cell Lymphoblastic Lymphoma/ALL Patient Advocacy Program are comprised of highly motivated high school students, college students, college graduates, medical students, or employed or retired persons who have the time to help a great cause.  

Please submit two paragraphs about your background and career (and career aspirations) and why you would like to be part of an ICAN Research team.  All positions are "virtual" meaning you work from your home or office computer and email your work in Word (and in some cases Excel, but you need not be fluent in Excel to join us).  

Because ICAN has a global volunteer network, all positions are unpaid.  ICAN is five-star rated on VolunteerMatch.

If you have peer-reviewed citations to SUBMIT to this part of Ogi's Program, please email to CitationReviewOgiKovacevic @askican.org.

Untitled Document